Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448227 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
A Phase 2 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00448227 is a Phase 2 study that has completed, run by Novartis. The registered enrollment target is 18 participants.
The verdict
NCT00448227, a Phase 2 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection
Interventions
- DRUG famciclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00448227
The ClinicalTrials.gov registry entry for NCT00448227 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which famciclovir is the first listed.
NCT00448227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00448227 about?
NCT00448227 is a clinical study titled "Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection". This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection
What is the current status of trial NCT00448227?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2007-10.
What interventions are being tested in trial NCT00448227?
The interventions under investigation include: famciclovir (DRUG).
Who is sponsoring clinical trial NCT00448227?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.